Literature DB >> 7562330

Loss of periodontal attachment in HIV-seropositive military personnel.

S L Tomar1, P A Swango, D V Kleinman, B A Burt.   

Abstract

The cross-sectional relationship between severe loss of periodontal attachment (LPA) and worsening immune status due to HIV infection was evaluated in 474 HIV-infected subjects (416 men, 58 women) aged 18 to 49 years who had been classified at stages 1 through 6 of the Walter Reed Army Institute of Research (WR) Staging Classification System. LPA was measured at four sites per tooth using a manual probe; severe LPA was defined as > or = 1 site/subject exhibiting > or = 5 mm LPA. Severe LPA was found in 94 (20%) of the subjects. Modeling with multiple logistic regression analysis revealed that WR stage and peripheral CD4+ lymphocyte cell counts were not significant independent predictors of severe LPA. Severe LPA was more common in subjects at WR stage 5 or 6 who exhibited oral candidiasis (OC), a marker of immune system damage, than in persons at those WR stages without OC (odds ratio = 7.85; 95% confidence interval (CI) = 1.94-31.81). After the analysis controlled for WR stage, younger subjects receiving AZT had greater odds of severe LPA than same-age subjects not taking the drug (e.g., odds ratio for subjects aged 30 years = 2.59; 95% CI = 1.22, 5.49). Other significant predictors in the model included male sex; retired military status; cigarette smoking; and presence of cratered, ulcerated, or necrotic interdental papillae. HIV-associated immune deficiency may be associated with localized severe LPA, but this may be an indirect association due to medication use, opportunistic infection, or other factors not captured by the WR staging system or peripheral CD4+ cell counts.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7562330     DOI: 10.1902/jop.1995.66.6.421

Source DB:  PubMed          Journal:  J Periodontol        ISSN: 0022-3492            Impact factor:   6.993


  6 in total

1.  Oral health status and treatment needs among HIV/AIDS patients attending antiretroviral therapy center in Western India: A cross-sectional study.

Authors:  Pankaj Chaudhary; Kanika Manral; Rahul Gupta; Aroon Kamal Singh Bengani; Bhumit Ishvarlal Chauhan; Deepanshu Arora
Journal:  J Family Med Prim Care       Date:  2020-07-30

2.  Characterizing traditionally defined periodontal disease in HIV+ adults.

Authors:  Lance T Vernon; Catherine A Demko; Christopher C Whalen; Michael M Lederman; Zahra Toossi; Mianda Wu; Yiping W Han; Aaron Weinberg
Journal:  Community Dent Oral Epidemiol       Date:  2009-07-14       Impact factor: 3.383

3.  Cohort study of HIV-positive and -negative methamphetamine users.

Authors:  Vladimir W Spolsky; Jason Clague; Vivek Shetty
Journal:  J Am Dent Assoc       Date:  2018-04-21       Impact factor: 3.634

4.  A Comparison of Chronic Periodontitis in HIV-Seropositive Subjects and the General Population in the Ga-Rankuwa Area, South Africa.

Authors:  Razia Khammissa; Liviu Feller; Mario Altini; Paul Fatti; Johan Lemmer
Journal:  AIDS Res Treat       Date:  2012-08-29

5.  Determinants of periodontitis according to the immunological and virological profiles of HIV-infected patients in Yaoundé, Cameroon.

Authors:  Joseph Fokam; Buolikeze Kuoh Nji Geh; Samuel Martin Sosso; Desire Takou; Ezechiel Semengue Ngufack; Alex Durand Nka; Anne-Cecile Z-K Bissek; David Mindja Eko; Alexis Ndjolo
Journal:  BMC Oral Health       Date:  2020-12-11       Impact factor: 2.757

6.  Effectiveness of Systematic Periodontal Treatment in Male HIV-Infected Patients after 9 Years: A Case Series.

Authors:  Rainer A Jordan; Adrian Lucaciu; Katharina Schaper; Hans-Peter Jöhren; Stefan Zimmer
Journal:  Adv Med       Date:  2018-08-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.